Neuralstem

$1.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-2.75%) Today
+$0.03 (1.69%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Neuralstem and other stocks, options, ETFs, and crypto commission-free!

About CUR

Neuralstem, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. Read More The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.

Employees
6
Headquarters
Germantown, Maryland
Founded
1996
Market Cap
3.72M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
37.74K
High Today
$1.85
Low Today
$1.77
Open Price
$1.84
Volume
48.43K
52 Week High
$24.40
52 Week Low
$1.50

Collections

CUR Earnings

-$1.45
-$0.97
-$0.50
-$0.02
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 14, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.